Recent News

By Category: Countermeasures

FDA Approves Inhalational Anthrax Therapeutic

Emergent BioSolutions Inc. today announced that the U.S. Food and Drug Administration has approved Anthrasil [Anthrax Immune Globulin Intravenous (Human)], also known as AIGIV, for treatment of inhalational anthrax in combination with appropriate antibacterial drugs. Achievement of this milestone triggers a $7 million payment to the company under a development contract with the Biomedical Advanced  Read More »

In Pictures: Air National Guard CBRN Training

More than 100 emergency management technicians of the Air National Guard gathered at the Guardian Centers of Georgia in Perry, Ga., in support of the Global Dragon deployment for training exercise on March 9, 2015. Airmen traveled from 20 states, representing more than 20 units and all 10 Federal Emergency Management Agencies.

Effect of Experimental Ebola Vaccine after High-Risk Exposure

A study appearing this week in JAMA analyzes the case of a 44-year-old U.S. physician who received an experimental Ebola vaccine after experiencing a needle stick while working in an Ebola treatment unit in Sierra Leone.

New 15-Minute Ebola Diagnostic to be Trialed in Guinea

A rapid, point-of-care diagnostic test for the Ebola virus will be trialed in the coming weeks at the Ebola treatment center in Conakry, Guinea

NIAID/GSK Experimental Ebola Vaccine Appears Safe

Results from a National Institutes of Health (NIH) Phase 1 clinical trial support accelerated development of the candidate vaccine to prevent Ebola virus disease.